This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Genesen Co., Ltd., Samsung Corning Precision Glass Co., Ltd.. Active years: 2009-2022.
Company Filing History:
Years Active: 2009-2022
Title: Hyeon Jun Shin: Innovator in Pharmaceutical and Semiconductor Technologies
Introduction
Hyeon Jun Shin is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the fields of pharmaceuticals and semiconductor technologies. With a total of 2 patents, his work focuses on innovative solutions that address critical health and technological challenges.
Latest Patents
Hyeon Jun Shin's latest patents include a peptide for toll-like receptor (TLR) inhibition and a semiconductor thin film using self-assembled monolayers. The first patent relates to a fusion polypeptide that inhibits various TLR signaling pathways, including TLR1/2, TLR2/6, TLR7, TLR8, TLR9, TLR4, and TLR3. This invention aims to prevent or treat diseases mediated by TLR pathways, such as autoimmune and inflammatory diseases, by effectively inhibiting TLR-mediated immune responses. The second patent describes a method for producing a semiconductor thin film that utilizes a self-assembled monolayer to enhance adhesion between insulating and semiconductor layers, resulting in high-quality, defect-free films.
Career Highlights
Throughout his career, Hyeon Jun Shin has worked with notable companies, including Samsung Corning Precision Glass Co., Ltd. and Genesen Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative technologies that bridge the gap between pharmaceuticals and semiconductor applications.
Collaborations
Hyeon Jun Shin has collaborated with esteemed colleagues such as Sang Dun Choi and Young Su Chung. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Hyeon Jun Shin is a distinguished inventor whose work in pharmaceutical and semiconductor technologies has the potential to make a significant impact on health and technology. His innovative patents and collaborations highlight his commitment to advancing these critical fields.